Brazil's Federal Revenue agency intercepted a massive shipment of controlled pharmaceuticals at Viracopos International Airport in Campinas, São Paulo. The operation, announced on Friday, uncovered 120 kilograms of medications during a routine customs inspection. The cargo was officially declared as dietary supplements bound for Portugal.
Laboratory analysis conducted by the University of Campinas (Unicamp) revealed the capsules contained high-risk pharmacological substances. Among the identified compounds were sibutramine and fluoxetine, both requiring strict medical control due to their potential health impacts. The shipment also contained furosemide, a diuretic that mandates special authorization for commercial sale and transport.
The scale of the seizure was substantial. Authorities recovered approximately 3,400 bottles holding around 61,000 individual capsules. The Federal Revenue noted that while similar interceptions have occurred previously, this particular operation represented a significantly larger volume compared to past cases.
The discovery highlights ongoing challenges in combating pharmaceutical smuggling through major Brazilian airports. Viracopos, one of the country's busiest cargo hubs, serves as a critical point for international shipments. The intended destination of Portugal suggests the operation may have been part of a broader international trafficking network.
The substances identified pose serious public health risks. Sibutramine, an appetite suppressant, has been withdrawn from many markets due to cardiovascular concerns. Fluoxetine, commonly known as Prozac, is a prescription antidepressant. Furosemide is a potent diuretic often misused for weight loss or to mask other substances.
This seizure underscores the vigilance of Brazilian customs officials in monitoring cargo shipments. The Federal Revenue continues to employ advanced screening techniques and laboratory partnerships to detect illicit pharmaceuticals disguised as legitimate products. Based on reporting from g1.